Key result
Goal-directed therapy during cardiopulmonary bypass is expected to improve patient outcomes by decreasing complications, reducing hospital stay, and decreasing morbidity.
Why the study?
Does goal-directed perfusion improve outcomes in patients undergoing cardiopulmonary bypass?
Does goal-directed perfusion improve outcomes in patients undergoing cardiopulmonary bypass?
Goal-directed perfusion during cardiopulmonary bypass is expected to improve patient outcomes based on the successes of goal-directed therapy in other critical care areas.
Expected benefits justify RCTs of goal-directed perfusion in CPB; leaves open routine use.
Goal-directed therapy is a patient care strategy that has been implemented to improve patient outcomes. The strategy includes aggressive patient management and monitoring during a period of critical care. Goal-directed therapy has been adapted to perfusion and has been designated goal-directed perfusion (GDP). Since this is a new concept in perfusion, the purpose of this study is to review goal-directed therapy research in other areas of critical care management and compare that process to improving patient outcomes following cardiopulmonary bypass. Various areas of goaldirected therapy literature were reviewed, including fluid administration, neurologic injury, tissue perfusion, oxygenation, and inflammatory response. Data from these studies was compiled to document improvements in patient outcomes. Goal-directed therapy has been demonstrated to improve patient outcomes when performed within the optimal time frame resulting in decreased complications, reduction in hospital stay, and a decrease in morbidity. Based on the successes in other critical care areas, GDP during cardiopulmonary bypass would be expected to improve outcomes following cardiac surgery.
No takes yet. Share an insight, caveat, or question.
Dijoy et al. (2015) conducted a review in Cardiac surgery requiring cardiopulmonary bypass. Goal-directed therapy and perfusion vs. Standard care was evaluated. Goal-directed therapy during cardiopulmonary bypass is expected to improve patient outcomes by decreasing complications, reducing hospital stay, and decreasing morbidity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: